Fluetonitazene (fluornitrazene, F-etonitazene, 2-fluoroetonitazene) is a benzimidazole derivative which is an opioid designer drug. It was patented in 2024 as a potential novel analgesic, but appeared on the illicit market at around the same time, first being identified in Germany in March 2024.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.